News Archive

SomaLogic Expands Its Commercial Capabilities with Three New Senior Leaders

SomaLogic Inc. announced today the appointments of Angela Bakker Lee, Ph.D. as executive vice president for healthcare markets, Tracy Hervey, MBA as executive vice president for life sciences markets and David McGovern, MBA as senior vice president of marketing. In these roles, Dr. Bakker Lee, Ms. Hervey and Mr. McGovern will drive business development and marketing efforts for SomaLogic’s proprietary protein measurement technology and growing portfolio of protein-based health information products.

read more

SomaLogic Adds $81M to Series A Financing Totaling $214M

SomaLogic, Inc. announced today that it added $81M to its current funding round with investments from a number of additional investors, for a total Series A raise of $214M. The funds raised in this round will facilitate improving, expanding and commercializing SomaLogic’s world-leading proteomic products in both the clinical and life science markets.

read more

Study Identifies Protein Targets for Drugs that Could be Used in the Fight Against COVID-19

An international consortium led by Medical Research Council researchers in the UK working with SomaLogic performed the largest genetic discovery of host proteins involved in SARS-CoV-2 infection or severe COVID-19. The results are being shared via an open access platform to help investigators around the world prioritize protein targets for new or repurposed drugs to treat COVID-19. The information may also help medical researchers identify patients who are more likely to develop a serious case of COVID-19.

read more

First Tests Launched in Japan Using SomaLogic’s SomaSignal™ Models

FonesLife Corporation, a subsidiary of NEC Solution Innovators, Ltd. of Japan, announced today that they will begin offering blood-based health tests built on the SomaLogic SomaScan® Platform to consumers in Japan. The tests, which deliver health-management information based on large-scale measurements of an individual’s blood proteins, are expected to help assess health and promote wellness in Japan’s rapidly aging population.

read more

SomaLogic Closes $121M Series A Financing Led by Casdin Capital

SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that the Company has successfully closed an Initial Series A capital raise of $121 Million. The Company anticipates that additional closings will occur within the next 90 days.

read more

SomaScan® Platform Reveals Space Mice Story

On December 5, 40 special mice were launched inside a Dragon capsule on a new Falcon 9 booster rocket from Cape Canaveral Air Force Station, headed toward the International Space Station for a 33-day mission. The SomaScan® Assay was used to measure proteomic changes in the mice after their spaceflight and revealed certain biochemical pathways that can be blocked to protect against both muscle and bone loss.

read more